(EMAILWIRE.COM, January 24, 2020 ) The increasing incidence of renal disorders, growing incidence of other chronic disorders impacting renal function, growing awareness and adoption of preventive healthcare approaches, implementation of favorable government initiatives to promote renal health, rising geriatric population, and increasing number of drug development initiatives are the key drivers for global creatinine measurement market.

The Creatinine Measurement market is expected to reach USD 564.5 Million by 2023 from USD 349.9 Million in 2017, at a CAGR of 8.4%.

+ Market Dynamics

+ Drivers

+ Increasing Prevalence of Chronic Diseases
+ Increasing R&D Spending
+ Increasing Healthcare Spending

Download PDF Brochure @
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=206847385

“The Jaffe’s kinetic method segment is expected to hold the largest in the market in 2018”
The creatinine measurement market, by test type, is segmented into the Jaffe’s kinetic method and enzymatic method. In 2018, the Jaffe’s kinetic method segment is expected to hold the largest share of the creatinine measurement market.

“Based on the type of sample, the blood/serum segment is expected to register the highest CAGR during the forecast period”
Based on type of sample the creatinine measurement market is segmented into blood/serum and urine samples. The blood/serum segment is expected to witness the highest CAGR over the forecast period. Most creatinine measurement kits and reagents are based on the analysis of creatinine in blood samples owing to its accuracy in inferring creatinine concentration and low risk of contamination.

View complete press release:-
https://www.marketsandmarkets.com/PressReleases/creatinine-measurement.asp